此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia

2019年1月28日 更新者:Abbott Medical Devices

A Randomized Controlled Pilot Study to Examine the Efficacy of Greater Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia

The study is designed as a prospective, randomized, double-blind, single center study with a 6 month duration post permanent system implantation. Forty patients will be implanted.

During trial stimulation, patients will be randomized into one of two study arms for two weeks. Crossover will occur at the 2 week study visit to the opposite group. After completion of these two arms, every patient will subsequently complete participation in the third study arm.

After completion of the third arm, patients will be evaluated to determine if they are a positive responder responder. If so, the patient will have the option of obtaining the permanent implant.

研究概览

地位

完全的

条件

研究类型

介入性

注册 (实际的)

40

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Antwerpen、比利时
        • Universitair Ziekenhuis Antwerpen

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Patients able to provide informed consent to participate in the study;
  2. Patient has had chronic widespread pain for at least 3 months in all 4 body quadrants;
  3. Patient has at least 11 out of 18 tender points based on the tender points examination;
  4. Patient has attempted "best" medical therapy and has tried and failed at least three documented medically supervised treatments (including, but not limited to drugs, physical therapy, acupuncture, etc.);
  5. Patient medication has remained stable for at least 4 weeks prior to baseline data collection;
  6. Psychological screening has been completed and the patient has been cleared by a psychologist as a suitable study candidate;
  7. Patient agrees not to add or increase medication throughout the randomization trial period of the study;
  8. Patient is willing to cooperate with the study requirements including compliance with the treatment regimen and completion of all office visits.

Exclusion Criteria:

  1. Patient has current evidence of any psychiatric disorder, as documented by the DSM-IV-TR criteria with psychotic characteristics, (e.g. bipolar disorder, major depressive disorder);
  2. Patient has been diagnosed with any disease mimicking the symptoms of the Fibromyalgia Syndrome (e.g. Epstein Barr, autoimmune diseases, etc.) that is not currently being treated or has not been stable for at least 6 months;
  3. Patient is currently in active menopause;
  4. Patient has been diagnosed with sleep apnea and is not currently involved in a treatment regime;
  5. Patient has a history of substance abuse or substance dependency in the past 6 months prior to baseline data collection;
  6. Patient currently participating in another clinical study;
  7. Patient with demand-type cardiac pacemakers, an infusion pump or any implantable neurostimulator device;
  8. Patient is likely to require an MRI evaluation in the future;
  9. Patient is not willing to maintain current medication regimen;
  10. Female candidates of child bearing potential who are pregnant (confirmed by positive urine/blood pregnancy test), not using adequate contraception as determined by the investigator, or nursing (lactating) a child.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
有源比较器:Suprathreshold Stimulation
Patients will be stimulated at supra-sensory threshold levels for two weeks using occipital stimulation
Occipital Nerve Stimulation will be used in each study arm using the Eon Mini neuromodulation system
假比较器:minimal stimulation
Patients will be stimulated at minimal stimulation for two weeks using occipital stimulation
Occipital Nerve Stimulation will be used in each study arm using the Eon Mini neuromodulation system
有源比较器:Subthreshold Stimulation
Patients will be stimulated at sub-sensory threshold stimulation for two weeks using occipital stimulation
Occipital Nerve Stimulation will be used in each study arm using the Eon Mini neuromodulation system

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Fibromyalgia Impact Questionnaire (FIQ)
大体时间:End of 6 week stimulation trial

The Fibromyalgia Impact Questionnaire (FIQ) is a self administered scale that was developed to measure fibromyalgia patient status, progress and outcomes. It measures the components of health that are most affected by fibromyalgia. The maximum score is 100 and a higher score indicates a greater impact of the syndrome on the person.

The change in the Fibromyalgia Impact Questionnaire (FIQ) will be analyzed and reported.

End of 6 week stimulation trial

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2010年6月1日

初级完成 (实际的)

2013年1月1日

研究完成 (实际的)

2013年1月1日

研究注册日期

首次提交

2011年2月14日

首先提交符合 QC 标准的

2011年2月16日

首次发布 (估计)

2011年2月17日

研究记录更新

最后更新发布 (实际的)

2019年1月30日

上次提交的符合 QC 标准的更新

2019年1月28日

最后验证

2019年1月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Occipital Stimulation的临床试验

3
订阅